BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37957688)

  • 1. Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism.
    Lin L; Ye Y; Fu H; Gu W; Zhao M; Sun J; Cao Z; Huang G; Xie Y; Liu F; Li L; Li Q; Mao J; Hu L
    Cell Commun Signal; 2023 Nov; 21(1):324. PubMed ID: 37957688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Human FSGS-Causing
    Hall G; Lane BM; Khan K; Pediaditakis I; Xiao J; Wu G; Wang L; Kovalik ME; Chryst-Stangl M; Davis EE; Spurney RF; Gbadegesin RA
    J Am Soc Nephrol; 2018 Aug; 29(8):2110-2122. PubMed ID: 30002222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of podocyte injury signaling pathway in steroid-resistant nephrotic syndrome and research progress in traditional Chinese medicine intervention].
    Yu WX; Yan W; Dai EL; Tian WX; Dang WJ
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3246-3254. PubMed ID: 37382008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
    Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
    Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
    Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
    J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway.
    Chen J; Yuan S; Zhou J; Huang X; Wu W; Cao Y; Liu H; Hu Q; Li X; Guan X; Yin S; Jiang J; Zhou Y; Zhou J
    Phytomedicine; 2022 Dec; 107():154477. PubMed ID: 36215790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
    Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
    J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Hermle T; Schneider R; Schapiro D; Braun DA; van der Ven AT; Warejko JK; Daga A; Widmeier E; Nakayama M; Jobst-Schwan T; Majmundar AJ; Ashraf S; Rao J; Finn LS; Tasic V; Hernandez JD; Bagga A; Jalalah SM; El Desoky S; Kari JA; Laricchia KM; Lek M; Rehm HL; MacArthur DG; Mane S; Lifton RP; Shril S; Hildebrandt F
    J Am Soc Nephrol; 2018 Aug; 29(8):2123-2138. PubMed ID: 29959197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis.
    Li Y; Xu C; Zhao F; Liu Q; Qiu X; Li M; Yang Y; Yu S; Tong H; Zhang L; Chen B; Qu L; Yu Z
    Hum Mol Genet; 2024 Apr; 33(8):667-676. PubMed ID: 38224683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific
    Widmeier E; Airik M; Hugo H; Schapiro D; Wedel J; Ghosh CC; Nakayama M; Schneider R; Awad AM; Nag A; Cho J; Schueler M; Clarke CF; Airik R; Hildebrandt F
    J Am Soc Nephrol; 2019 Mar; 30(3):393-405. PubMed ID: 30737270
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Bierzynska A; Soderquest K; Dean P; Colby E; Rollason R; Jones C; Inward CD; McCarthy HJ; Simpson MA; Lord GM; Williams M; Welsh GI; Koziell AB; Saleem MA; ;
    J Am Soc Nephrol; 2017 May; 28(5):1614-1621. PubMed ID: 27932480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
    Ashraf S; Gee HY; Woerner S; Xie LX; Vega-Warner V; Lovric S; Fang H; Song X; Cattran DC; Avila-Casado C; Paterson AD; Nitschké P; Bole-Feysot C; Cochat P; Esteve-Rudd J; Haberberger B; Allen SJ; Zhou W; Airik R; Otto EA; Barua M; Al-Hamed MH; Kari JA; Evans J; Bierzynska A; Saleem MA; Böckenhauer D; Kleta R; El Desoky S; Hacihamdioglu DO; Gok F; Washburn J; Wiggins RC; Choi M; Lifton RP; Levy S; Han Z; Salviati L; Prokisch H; Williams DS; Pollak M; Clarke CF; Pei Y; Antignac C; Hildebrandt F
    J Clin Invest; 2013 Dec; 123(12):5179-89. PubMed ID: 24270420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
    Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
    Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
    Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
    J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huangkui capsule alleviates doxorubicin-induced proteinuria via protecting against podocyte damage and inhibiting JAK/STAT signaling.
    Zhao L; Han S; Chai C
    J Ethnopharmacol; 2023 Apr; 306():116150. PubMed ID: 36608778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
    Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
    J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation.
    Wang L; Liu H; Wang Y; Hong X; Huang X; Han M; Wang D; Shan W; Li P; Gu H; Liu B; Bao K
    Drug Des Devel Ther; 2023; 17():1847-1861. PubMed ID: 37360573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TBC1D8B Loss-of-Function Mutations Lead to X-Linked Nephrotic Syndrome via Defective Trafficking Pathways.
    Dorval G; Kuzmuk V; Gribouval O; Welsh GI; Bierzynska A; Schmitt A; Miserey-Lenkei S; Koziell A; Haq S; Benmerah A; Mollet G; Boyer O; Saleem MA; Antignac C
    Am J Hum Genet; 2019 Feb; 104(2):348-355. PubMed ID: 30661770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
    Wang J; Fu D; Senouthai S; You Y
    Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
    Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
    Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.